SHRs have been found to have reduced dopamine transporter (DAT) density and altered dopamine receptor (DR) function, leading to imbalances in DA levels that are believed to underlie many of the symptoms of ADHD [67,68]. Here, SLC6A3 is linked to attention deficit-hyperactivity disorder.